{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:01:20Z","timestamp":1780092080391,"version":"3.54.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jocn.2022.05.007","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T23:29:26Z","timestamp":1652830166000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort"],"prefix":"10.1016","volume":"101","author":[{"given":"Hai-yun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-san","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-wu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jocn.2022.05.007_b0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ana.25421","article-title":"Development of the clinical assessment scale in autoimmune encephalitis","volume":"85","author":"Lim","year":"2019","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.jocn.2022.05.007_b0010","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1590\/S0004-282X2011000700028","article-title":"Subacute cognitive impairment, hyponatremia and mesial temporal lobe lesions: a typical presentation of voltage-gated potassium channel (VGKC) antibody-associated limbic encephalitis","volume":"69","author":"Saccardi","year":"2011","journal-title":"Arq Neuropsiquiatr"},{"issue":"10","key":"10.1016\/j.jocn.2022.05.007_b0015","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1590\/1806-9282.66.10.1327","article-title":"Autoimmune encephalitis (AIE)","volume":"66","author":"Cafalli","year":"1992","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.jocn.2022.05.007_b0020","doi-asserted-by":"crossref","first-page":"117216","DOI":"10.1016\/j.jns.2020.117216","article-title":"Acute radiological features facilitate diagnosis and prognosis of anti-N-methyl-d-aspartate receptor (NMDAR) and anti-voltage-gated potassium channel (VGKC) encephalitis in adults","volume":"419","author":"Neo","year":"2020","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.jocn.2022.05.007_b0025","first-page":"605","article-title":"Anti-VGKC Complex Antibodies and Limbic Encephalitis","volume":"73","author":"Tanaka","year":"2021","journal-title":"Brain Nerve"},{"key":"10.1016\/j.jocn.2022.05.007_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.642078","article-title":"Characteristics and Prognosis of Autoimmune Encephalitis in the East of China: A Multi-Center Study","volume":"12","author":"Qiao","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jocn.2022.05.007_b0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/NDT.S292343","article-title":"Clinical features and long-term outcomes of anti-leucine-rich glioma-inactivated 1 encephalitis: a multi-center study","volume":"17","author":"Qiao","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"10.1016\/j.jocn.2022.05.007_b0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2022.05.007_b0045","doi-asserted-by":"crossref","first-page":"106187","DOI":"10.1016\/j.clineuro.2020.106187","article-title":"Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies","volume":"197","author":"Jia","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"issue":"19","key":"10.1016\/j.jocn.2022.05.007_b0050","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1212\/WNL.0b013e3181a55eb3","article-title":"Histopathology of VGKC antibody-associated limbic encephalitis","volume":"72","author":"Khan","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jocn.2022.05.007_b0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00018-019-03269-0","article-title":"Insights into the mechanisms of epilepsy from structural biology of LGI1-ADAM22","volume":"77","author":"Yamagata","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jocn.2022.05.007_b0060","doi-asserted-by":"crossref","first-page":"107462","DOI":"10.1016\/j.yebeh.2020.107462","article-title":"Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review","volume":"112","author":"Roberto","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jocn.2022.05.007_b0065","doi-asserted-by":"crossref","first-page":"633999","DOI":"10.3389\/fneur.2021.633999","article-title":"Autoimmune encephalitis in late-onset seizures: when to suspect and how to treat","volume":"12","author":"Susse","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jocn.2022.05.007_b0070","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.seizure.2021.07.005","article-title":"Association between autoimmune encephalitis and epilepsy: Systematic review and meta-analysis","volume":"91","author":"Chen","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.jocn.2022.05.007_b0075","doi-asserted-by":"crossref","first-page":"577271","DOI":"10.1016\/j.jneuroim.2020.577271","article-title":"The neuropsychological spectrum of anti-LGI1 antibody mediated autoimmune encephalitis","volume":"345","author":"Griffith","year":"2020","journal-title":"J Neuroimmunol"},{"issue":"14","key":"10.1016\/j.jocn.2022.05.007_b0080","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.jocn.2022.05.007_b0085","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1212\/01.wnl.0000326572.93762.51","article-title":"Immunotherapy-responsive seizure-like episodes with potassium channel antibodies","volume":"71","author":"Irani","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jocn.2022.05.007_b0090","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00415-020-10357-w","article-title":"CASPR2 antibody-related movement disorders: case series","volume":"268","author":"Scotton","year":"2021","journal-title":"J Neurol"},{"issue":"10","key":"10.1016\/j.jocn.2022.05.007_b0095","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1793","article-title":"Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: A systematic review","volume":"10","author":"Ghimire","year":"2020","journal-title":"Brain Behav"},{"key":"10.1016\/j.jocn.2022.05.007_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.652864","article-title":"Clinical Character of CASPR2 Autoimmune Encephalitis: A Multiple Center Retrospective Study","volume":"12","author":"Qin","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jocn.2022.05.007_b0105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00415-009-5370-5","article-title":"VGKC antibody-associated encephalitis, microbleeds and progressive brain atrophy","volume":"257","author":"Kapina","year":"2010","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.jocn.2022.05.007_b0110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s13760-020-01446-8","article-title":"Effectiveness of immunotherapy in a CASPR2 and LGI1 antibody-positive elderly patient with Isaacs' syndrome: a case study","volume":"121","author":"Ye","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.jocn.2022.05.007_b0115","doi-asserted-by":"crossref","DOI":"10.1002\/ana.26189","article-title":"LGI1- versus CASPR2-antibody neuropathic pain: clinical and biological comparisons","author":"Ramanathan","year":"2021","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.jocn.2022.05.007_b0120","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5698\/1535-7597-14.4.180","article-title":"The Face (and Arm) of Treatment for Seizures in VGKC\/LGI1 Antibody-Associated Limbic Encephalitis","volume":"14","author":"Chang","year":"2014","journal-title":"Epilepsy Curr"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822002211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822002211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:31:25Z","timestamp":1760823085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586822002211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":24,"alternative-id":["S0967586822002211"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2022.05.007","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2022.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}